CVE-2022-0020

Cortex XSOAR: Stored Cross-Site Scripting (XSS) Vulnerability in Web Interface

Description

A stored cross-site scripting (XSS) vulnerability in Palo Alto Network Cortex XSOAR web interface enables an authenticated network-based attacker to store a persistent javascript payload that will perform arbitrary actions in the Cortex XSOAR web interface on behalf of authenticated administrators who encounter the payload during normal operations. This issue impacts: All builds of Cortex XSOAR 6.1.0; Cortex XSOAR 6.2.0 builds earlier than build 1958888.

Remediation

Solution:

  • This issue is fixed in Cortex XSOAR 6.2.0 build 1958888 and all later Cortex XSOAR versions.

Workaround:

  • There are no known workarounds for this issue.

Category

6.8
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 1.11% Top 25%
Vendor Advisory paloaltonetworks.com
Affected: Palo Alto Networks Cortex XSOAR
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-0020?
CVE-2022-0020 has been scored as a medium severity vulnerability.
How to fix CVE-2022-0020?
To fix CVE-2022-0020: This issue is fixed in Cortex XSOAR 6.2.0 build 1958888 and all later Cortex XSOAR versions.
Is CVE-2022-0020 being actively exploited in the wild?
It is possible that CVE-2022-0020 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-0020?
CVE-2022-0020 affects Palo Alto Networks Cortex XSOAR.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.